Data Report

State of Biotech Funding — All-Time

Tracked funding for Biotech companies across all years — totals, largest rounds, stage mix, and recent quarterly trends.

Report generated October 2026 · Figures in USD

Funding totals and round counts include only positive known USD amounts. Company and stage counts also include rounds without a known USD amount.

$367.5B

Funding with USD Amounts

9,313

Rounds with USD Amounts

4,303

Companies with Funding Events

$5.0B

Largest Round

Funding Trend

Funding with known USD amounts per quarter. The current quarter is still filling in.

Year-only estimates are excluded from quarterly totals. Headline totals may include them.

$9.0B
$7.4B
$9.1B
$14.1B
$10.0B
$11.8B
$6.2B
$310.0M
'25 Q1
'25 Q2
'25 Q3
'25 Q4
'26 Q1
'26 Q2
'26 Q3
'26 Q4
QTD

Peak quarter '25 Q4 at $14.1B. Latest complete quarter (2026Q3): ▼ 48% QoQ · ▼ 32% YoY. Current quarter (QTD) is still filling in.

Largest Rounds

The biggest tracked Biotech funding rounds with known USD amounts. Tap any company for its full profile.

Rounds by Stage

Most common stages among all eligible funding events, including rounds without a known USD amount.

1Grant
3,206
2Series A
1,949
3Seed
1,637
4Series B
1,300
5Venture Round
859
6Series C
612
7Series D
261
8Extension Round
260

Explore More

Methodology

Figures are aggregated from Indexed's live database of 98,772 company profiles and 22,284 investors. Company totals include publicly listed and inactive businesses. Company funding totals and individual event tables have different coverage; each report states its population and period. Amounts are shown in USD where available, and undisclosed amounts are excluded from dollar totals. Source coverage varies by record; follow company and event links to inspect supporting evidence. Report generated October 2026. Free to cite with attribution to Indexed.

Totals include recorded grants and other qualifying funding, not just equity. Debt financing, IPO proceeds and exit consideration are excluded from these funding totals. Valuations are company values, not capital raised. How funding is counted.